B2B healthcare market Aumet Sunday, December 26, announced the acquisition of an Egypt-based healthcare supply chain solution, offering Platform One, giving the US company that serves the Middle East and North Africa more than 5 000 pharmacies in its portfolio.
This acquisition allows Aumet to establish itself in Saudi Arabia, the United Arab Emirates, Egypt and Jordan.
Aumet connects pharmacies and pharmaceutical suppliers in the Middle East and North Africa through its B2B platform, helping manufacturers, distributors and healthcare providers to exchange data to improve the overall efficiency of the business and decision making.
Aumet now has access to Platform One’s user network, and Platform One will lead Aumet’s operations in Egypt under the agreement.
“Egypt is a crucial market for us, and Platform One has already laid the groundwork for what will follow,” said the CEO of Aumet. Yahya Aqel in a Martech Vibe report on Sunday (December 26). “The synergies that resonated between Aumet and Platform One were clear from the initial phases of interaction, as both companies are providers of technology-driven digital solutions for the healthcare industry. “
Pharmacies in Egypt will have access to the full range of Aumet products, including Aumet MarketPlace, which connects pharmacies with pharmaceutical suppliers via mobile app and web apps, Aumet Pharmacy, a point-of-sale management software solution and stocks.
The collaboration will help pharmacists manage their cash flow and automate their orders through the “Automatic Inventory Replenishment” functionality connected to Aumet MarketPlace and the Aumet Pay payment gateway for pharmacies and their suppliers.
Related: CVS expands healthcare services, expects sales to boom
Earlier this month, drugstore chain and health insurer CVS Health said during its 2021 Investor Day presentations that its sales are expected to increase as it continues to expand its services – to the both in stores and in people’s homes – as part of its quest to make healthcare more accessible. and easier to pay.
New CEO of CVS Health Karen lynch said on Investor Day that the company is rapidly adjusting to changing consumer habits and is benefiting from the momentum of building consumer confidence since the start of the COVID-19 pandemic.
CVS has distributed more than 50 million COVID vaccines and performed around 29 million coronavirus tests until the end of November, she said. Vaccine injections and testing have attracted more than 32 million new customers to CVS stores.